18 results with keyword: 'systemic lupus erythematosus pathophysiology'
Induced Glomerular Injury Management and treatment: -Immunosuppressant agents -Mycophenolate Mofetil and intravenous Cyclophosphamide If not treated: -Lupus Nephritis -Acute
N/A
As departments and faculty control and determine the appropriate pedagogies for their courses, the university will not agree in a contract with any private or public entity to deliver
N/A
TREAT SYSTEMIC LUPUS ERYTHEMATOSUS, 2012-2018 (%) 8 FIGURE 1 DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS 32 FIGURE 2 PATIENT CARE PATH IN SYSTEMIC LUPUS ERYTHEMATOSUS 35 FIGURE
N/A
-Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic
N/A
SLE: systemic lupus erythematosus; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; LN: lupus nephritis; ELISA: enzyme-linked immunosorbent assay; CIA:
N/A
Abbreviations: RCT: randomised controlled trial; SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; SSc: systemic sclerosis; *
N/A
* SLE ⫽ systemic lupus erythematosus; VAS ⫽ visual analog scale; ECLAM ⫽ European Consensus Lupus Activity measurement; SLEDAI ⫽ Systemic Lupus Erythematosus Disease Activity
N/A
RTA: renal tubular acidosis; SLE: systemic lupus erythematosus; SLEDAI: systemic lupus erythematosus disease activity index; TTKG: transtubular potassium
N/A
lung disease in systemic lupus erythematosus. Semin Arthritis Rheum. Pulmonary manifestations of. systemic lupus erythematosus. Clin Chest Med. Pulmonary involvement in systemic
N/A
Abbreviations: SLE: Systemic Lupus Erythematosus; CCLE: Chronic Cutaneous Lupus Erythematosus; DLE: Discoid Lupus Erythematosus; PsA: Psoriatic Arthritis; Ps: Psoriasis; TNF:
N/A
Background: We present a rare case of secondary angle closure glaucoma due to systemic lupus erythematosus choroidopathy as initial presentation of systemic lupus
N/A
(2013) Successful Hematopoietic Cell Transplanta- tion in a Child with Sickle Cell Disease and Systemic Lupus Erythematosus. (2010) The Overlap of Systemic Lupus Erythematosus
N/A
Figure 8 Americas: Systemic Lupus Erythematosus Treatment Market Share, by Region, 2020 Figure 9 North America: Systemic Lupus Erythematosus Treatment Market Share, by Country,
N/A
Keywords Lupus, cutaneous (CLE) and systemic lupus erythematosus (SLE), ‘discoid’ lupus erythematosus (DLE), efficacy endpoints, disease activity indices, claims 12... Guideline
N/A
SLE: Systemic Lupus Erythematosus; OR: Odds Ratio; aPL: Antiphospholipid antibodies; APS: Antiphospholipid syndrome; SLICC: Systemic Lupus International Collaborating Clinics; LA:
N/A